Belkin Vision's Eagle Glaucoma-Treating Laser Gets CE Mark

Israel-based Belkin Vision has received a CE mark certification for its automated, noncontact Eagle laser treatment for glaucoma and ocular hypertension.

The automated laser trabeculoplasty — a treatment used to reduce pressure in the eye — reduces the need for specialized training and allows it to be used by all ophthalmologists, the company said.

The UK’s National Institute for Healthcare Excellence recently recommended laser therapy as a first-line treatment for newly diagnosed glaucoma patients following similar guidelines by the European Glaucoma Society.

Belkin plans to begin marketing the Eagle laser in Europe in the second half of 2022.